Injectable growth/differentiation factor-5-recombinant human collagen composite induces endochondral ossification via Sry-related HMG box 9 (Sox9)expression and angiogenesis in murine calvariae

Journal of Periodontal Research

Volumn 43, Issue 5, 2008, Pages 483-489

  Kadomatsu, H ^a   Matsuyama, T ^a   Yoshimoto, T ^a   Negishi, Y ^c   Sekiya, H ^d   Yamamoto, M ^b   Izumi, Y ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b SHOWA UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

^c TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^d TOHO UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Bone formation; Recombinant human collagen; Recombinant human growth differentiation factor 5

Indexed keywords

COLLAGEN TYPE 1; GROWTH DIFFERENTIATION FACTOR 5; RECOMBINANT PROTEIN; SOX9 PROTEIN, MOUSE; TRANSCRIPTION FACTOR SOX9; VASCULOTROPIN A; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ANIMAL; ARTICLE; BIOSYNTHESIS; BONE DEVELOPMENT; CELL CULTURE; CYTOLOGY; DRUG EFFECT; FIBROBLAST; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE; NEWBORN; OSTEOBLAST; PERIOSTEUM; PHYSIOLOGY; SKULL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; COLLAGEN TYPE I; FIBROBLASTS; GROWTH DIFFERENTIATION FACTOR 5; HUMANS; IMMUNOHISTOCHEMISTRY; INJECTIONS, SUBCUTANEOUS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOBLASTS; OSTEOGENESIS; PERIOSTEUM; RECOMBINANT PROTEINS; SKULL; SOX9 TRANSCRIPTION FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VON WILLEBRAND FACTOR;

EID: 50849091284     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2007.01023.x     Document Type: Article

References (33)

1. Wissink MJ, Beernink R, Poot AA et al. Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices. J Control Release 2000 64 : 103 114.
2. Zisch AH, Schenk U, Schense JC, Sakiyama-Elbert SE, Hubbell JA. Covalently conjugated VEGF-fibrin matrices for endothelialization. J Control Release 2001 72 : 101 113.
3. Fertala A, Sieron AL, Ganguly A et al. Synthesis of recombinant human procollagen II in a stably transfected tumour cell line (HT1080). Biochem J 1994 298 : 31 37.
4. Chen M, Costa FK, Lindvay CR, Han YP, Woodley DT. The recombinant expression of full-length type VII collagen and characterization of molecular mechanisms underlying dystrophic epidermolysis bullosa. J Biol Chem 2002 277 : 2118 2124.
5. Tomita M, Kitajima T, Yoshizato K. Formation of recombinant human procollagen I heterotrimers in a baculovirus expression system. J Biochem (Tokyo) 1997 121 : 1061 1069.
6. Nokelainen M, Helaakoski T, Myllyharju J et al. Expression and characterization of recombinant human type II collagens with low and high contents of hydroxylysine and its glycosylated forms. Matrix Biol 1998 16 : 329 338.
7. Buechter DD, Paolella DN, Leslie BS et al. Co-translational incorporation of trans-4-hydroxyproline into recombinant proteins in bacteria. J Biol Chem 2003 278 : 645 650.
8. Yang C, Hillas PJ, Baez JA et al. The application of recombinant human collagen in tissue engineering. Biodrugs 2004 18 : 103 119.
9. Wikesjo UM, Guglielmoni P, Promsudthi A et al. Periodontal repair in dogs: effect of rhBMP-2 concentration on regeneration of alveolar bone and periodontal attachment. J Clin Periodontol 1999 26 : 392 400.
10. Blumenthal NM, Koh-Kunst G, Alves ME et al. Effect of surgical implantation of recombinant human bone morphogenetic protein-2 in a bioabsorbable collagen sponge or calcium phosphate putty carrier in intrabony periodontal defects in the baboon. J Periodontol 2002 73 : 1494 1506.
11. Selvig KA, Sorensen RG, Wozney JM, Wikesjo UM. Bone repair following recombinant human bone morphogenetic protein-2 stimulated periodontal regeneration. J Periodontol 2002 73 : 1020 1029.
12. King GN, Hughes FJ. Effects of occlusal loading on ankylosis, bone, and cementum formation during bone morphogenetic protein-2-stimulated periodontal regeneration in vivo. J Periodontol 1999 70 : 1125 1135.
13. Storm EE, Huynh TV, Copeland NG et al. Limb alterations in brachypodism mice due to mutations in a new member of the TGFβ-superfamily. Nature 1994 368 : 639 643.
14. Chang SC, Hoang B, Thomas JT et al. Cartilage-derived morphogenetic proteins. New members of the transforming growth factor-β superfamily predominantly expressed in long bones during human embryonic development. J Biol Chem 1994 269 : 28227 28234.
15. Morotome Y, Goseki-Sone M, Ishikawa I, Oida S. Gene expression of growth and differentiation factors-5-6, and -7 in developing bovine tooth at the root forming stage. Biochem Biophys Res Commun 1998 244 : 85 90.
16. Sena K, Morotome Y, Baba O et al. Gene expression of growth differentiation factors in the developing periodontium of rat molars. J Dent Res 2003 82 : 166 171.
17. Buxton P, Edwards C, Archer CW, Francis-West P. Growth/differentiation factor-5 (GDF-5) and skeletal development. J Bone Joint Surg Am 83 A Suppl. S23 S30.
18. Archer CW, Dowthwaite GP, Francis-West P. Development of synovial joints. Birth Defects Res C Embryo Today 2003 69 : 144 155.
19. Settle SH Jr., Rountree RB, Sinha A et al. Multiple joint and skeletal patterning defects caused by single and double mutations in the mouse Gdf6 and Gdf5 genes. Dev Biol 2003 254 : 116 130.
20. Edwards CJ, Francis-West PH. Bone morphogenetic proteins in the development and healing of synovial joints. Semin Arthritis Rheum 2001 31 : 33 42.
21. Coleman CM, Tuan RS. Functional role of growth/differentiation factor 5 in chondrogenesis of limb mesenchymal cells. Mech Dev 2003 120 : 823 836.
22. Wolfman NM, Hattersley G, Cox K et al. Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7, members of the TGF-β gene family. J Clin Invest 1997 100 : 321 330.
23. Simank HG, Sergi C, Jung M et al. Effects of local application of growth and differentiation factor-5 (GDF-5) in a full-thickness cartilage defect model. Growth Factors 2004 22 : 35 43.
24. Kuniyasu H, Hirose Y, Ochi M et al. Bone augmentation using rhGDF-5-collagen composite. Clin Oral Implants Res 2003 14 : 490 499.
25. Yoshimoto T, Yamamoto M, Kadomatsu H et al. Recombinant human growth/differentiation factor-5 (rhGDF-5) induced bone formation in murine calvariae. J Periodont Res 2006 41 : 140 147.
26. Kim DS, Korting HC, Schafer-Korting M. Effects of growth factors on the proliferation of human keratinocytes and fibroblasts in vitro. Pharmazie 1998 53 : 51 57.
27. Nakamura T, Yamamoto M, Tamura M, Izumi Y. Effects of growth/differentiation factor-5 on human periodontal ligament cells. J Periodont Res 2003 38 : 597 605.
28. Yamashita H, Shimizu A, Kato M et al. Growth/differentiation factor-5 induces angiogenesis in vivo. Exp Cell Res 1997 235 : 218 226.
29. Colnot CI, Helms JA. A molecular analysis of matrix remodeling and angiogenesis during long bone development. Mech Dev 2001 100 : 245 250.
30. Zelzer E, McLean W, Ng YS et al. Skeletal defects in VEGF (120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development 2002 129 : 1893 1904.
31. Olsen BR, Reginato AM, Wang W. Bone development. Annu Rev Cell Dev Biol 2000 16 : 191 220.
32. Hatakeyama Y, Tuan RS, Shum L. Distinct functions of BMP4 and GDF5 in the regulation of chondrogenesis. J Cell Biochem 2004 91 : 1204 1217.
33. Wright E, Hargrave MR, Christiansen J et al. The Sry-related gene Sox9 is expressed during chondrogenesis in mouse embryos. Nat Genet, 1995 9 : 15 20.